Nitrosamine Impurities; What’s the Impact on IMPs
October 13, 2020
N-nitrosamines are a regulatory and industry hot topic and whilst the focus has been on marketed products rather than development portfolios, there is an impact on investigational medicinal product development and manufacture. This webinar, led by Paul Cummings, will discuss nitrosamine impurities including key considerations when developing an IMP, the risks of delaying a formal risk assessment and more.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
GMP and Regulatory Compliance Virtual SupplySide Connect New Jersey Training
January 30, 2025NSF is offering a comprehensive GMP and regulatory compliance training program of virtual classroom-based courses for dietary supplement and cosmetics industry professionals at SupplySide Connect 2025.
Read the Story
NSF Granted Reauthorization as a CMMC Third-Party Assessment Organization
January 8, 2025Cyber AB’s reauthorization allows NSF to conduct CMMC Level 2 assessments and certifications for Department of Defense Suppliers.
Read the Story
NSF Celebrates 50 Years of the Safe Drinking Water Act
December 16, 2024The Safe Drinking Water Act resulted in the creation of NSF/ANSI/CAN 60 and NSF/ANSI/CAN 61, helping safeguard global drinking water.
Read the Story
Brooklands New Media’s Publication On NSF’s Global Animal Wellness Standards (GAWS) Not Endorsed by NSF
November 25, 2024NSF is aware that a firm called Brooklands New Media plans to publish a book to mark the 5th anniversary of NSF Global Animal Wellness Standards (GAWS).
Read the Story